Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Soria

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Trials|October 3, 2021
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocolI García-García, P Guerra-García, C Ferreras, et al.
Pflugers Archiv : European Journal of Physiology|June 23, 2000
Engineering pancreatic isletsB Soria, E Andreu, G Berná, et al.
The Journal of Clinical Investigation|July 21, 2000
Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose toleranceA Charollais, A Gjinovci, J Huarte, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
Eclinicalmedicine|August 18, 2021
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)A Pérez-Martínez, M Mora-Rillo, C Ferreras, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Trials|October 3, 2021
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocolI García-García, P Guerra-García, C Ferreras, et al.
Pflugers Archiv : European Journal of Physiology|June 23, 2000
Engineering pancreatic isletsB Soria, E Andreu, G Berná, et al.
The Journal of Clinical Investigation|July 21, 2000
Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose toleranceA Charollais, A Gjinovci, J Huarte, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
Eclinicalmedicine|August 18, 2021
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)A Pérez-Martínez, M Mora-Rillo, C Ferreras, et al.
Pageof 10